Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments. How ...
Apr 23, 2019
0
0
Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) ...
Apr 17, 2019
0
23
(HealthDay)—The Tandem Diabetes Care t-Slim X2 insulin pump, which allows a patient to customize treatment, has been approved by the U.S. Food and Drug Administration.
Feb 15, 2019
0
2
Tea infusions made from two species of the wormwood plant cured the tropical disease schistosomiasis significantly faster than the drug most commonly used against the ailment—and with no adverse side effects—in a large ...
Dec 7, 2018
0
2
(HealthDay)—Truxima (rituximab-abbs) has been approved by the U.S. Food and Drug Administration as the first biosimilar to the non-Hodgkin's lymphoma drug Rituxan, the agency said Wednesday.
Nov 29, 2018
0
0
A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the National Institutes of Health. The early-phase clinical trial will evaluate whether periodic infusions of two highly ...
Sep 20, 2018
0
0
The World Health Organization said Tuesday it is "cautiously optimistic" about efforts to curb the spread of Ebola in an urban area in Congo, although the lethal virus is still reported in at least two remote areas.
May 29, 2018
0
1
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...
May 21, 2018
0
7
Two genetically modified broadly neutralizing antibodies (bNAbs) protected rhesus macaques from an HIV-like virus, report scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National ...
Apr 16, 2018
0
10
(HealthDay)—Use of ketamine at induction followed by reduced propofol infusion rate for maintenance is associated with shorter recovery times for children undergoing magnetic resonance imaging with deep sedation, according ...
Feb 7, 2018
0
1
